Shares of PetIQ Inc (NASDAQ:PETQ) have earned an average rating of “Buy” from the eight analysts that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $27.40.
A number of research analysts recently issued reports on PETQ shares. Jefferies Group raised their target price on shares of PetIQ from $25.00 to $26.00 and gave the company a “hold” rating in a research note on Tuesday, November 7th. Zacks Investment Research upgraded shares of PetIQ from a “hold” rating to a “buy” rating and set a $24.00 price target on the stock in a research report on Tuesday, January 9th. Finally, BidaskClub upgraded shares of PetIQ from a “hold” rating to a “buy” rating in a research report on Tuesday, January 23rd.
PetIQ (PETQ) traded up $0.06 during trading hours on Tuesday, reaching $22.73. 240,964 shares of the company were exchanged, compared to its average volume of 272,690. PetIQ has a 1-year low of $17.03 and a 1-year high of $28.23. The company has a current ratio of 6.83, a quick ratio of 4.67 and a debt-to-equity ratio of 0.19.
A number of hedge funds and other institutional investors have recently bought and sold shares of PETQ. American International Group Inc. acquired a new stake in PetIQ in the 3rd quarter worth $131,000. Wells Fargo & Company MN acquired a new stake in PetIQ in the 3rd quarter worth $204,000. California State Teachers Retirement System acquired a new stake in PetIQ in the 3rd quarter worth $320,000. Schwab Charles Investment Management Inc. acquired a new stake in PetIQ in the 3rd quarter worth $344,000. Finally, New York State Common Retirement Fund acquired a new stake in PetIQ in the 3rd quarter worth $448,000. Institutional investors own 57.54% of the company’s stock.
PetIQ Company Profile
PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.